(Q45237330)

11 December 2017

title

Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II study (English)

1 reference

11 December 2017

1 reference

1 reference

1 reference

0 references

Adamo V

1

1 reference

11 December 2017

Scimone A

2

1 reference

11 December 2017

Maisano R

3

1 reference

11 December 2017

Altavilla G

4

1 reference

11 December 2017

Ferraro G

5

1 reference

11 December 2017

Laudani A

6

1 reference

11 December 2017

Pergolizzi S

7

1 reference

11 December 2017

Zanghì M

8

1 reference

11 December 2017

publication date

1 February 1999

1 reference

11 December 2017

published in

Journal of Chemotherapy

1 reference

11 December 2017

volume

11

1 reference

11 December 2017

issue

1

1 reference

11 December 2017

page(s)

74-77

1 reference

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.1.74

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.1.74

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.1.74

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.1.74

A phase II trial of etoposide, leucovorin and 5-fluorouracil (ELF) in patients with advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.1.74

Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.1.74

21 January 2018

Identifiers

DOI

10.1179/JOC.1999.11.1.74

1 reference

11 December 2017

1 reference